Forensic interrogation of diabetic endothelitis in cardiovascular diseases and clinical translation in heart failure

Merlin C Thomas1, Pupalan Iyngkaran2

  • 1Department of Diabetes, Monash University, Melbourne 3004, Victoria, Australia. merlin.thomas@monash.edu.

World Journal of Cardiology
|September 4, 2020
PubMed

Insights

Diabetic heart disease (DHD) involves inflammation of blood vessels, known as endothelitis, contributing to heart failure with preserved ejection fraction (HFpEF). This review explores microscopic changes in diabetic endothelitis and its clinical link to HFpEF.

Area of Science:

  • Cardiology
  • Endocrinology
  • Pathology

Background:

  • Diabetic heart disease (DHD) is a significant complication of diabetes mellitus (DM).
  • Endothelitis, or inflammation of the vascular endothelium, is a key pathological feature in DM complications.
  • Heart failure with preserved ejection fraction (HFpEF) is common in diabetic patients, but its pathophysiology is not fully understood.

Purpose of the Study:

  • To explore the microscopic aspects of diabetic endothelitis.
  • To establish a clinical link between diabetic endothelitis and HFpEF.

Main Methods:

  • This is a review article, synthesizing existing literature.
  • Focuses on microscopic pathological changes in diabetic endothelitis.
  • Correlates these microscopic findings with clinical manifestations of HFpEF.

Main Results:

  • Diabetic endothelitis is a prevalent feature in patients with end-organ complications of DM, including DHD.
  • Microscopic changes in endothelitis contribute to the development of HFpEF.
  • Significant gaps remain in understanding the transition from DM to clinical cardiovascular complications.

Conclusions:

  • Diabetic endothelitis is a critical microscopic factor in the development of DHD and HFpEF.
  • Further research is needed to elucidate the full pathophysiological mechanisms linking DM, endothelitis, and HFpEF.
  • Understanding these microscopic aspects may lead to improved clinical management strategies for diabetic cardiovascular complications.

Related Concept Videos

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
217
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
312
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
2.8K